| CYCN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CYCN shares outstanding history going back to 3/18/2019:
Also see: CYCN Market Cap History CYCN YTD Return |
CYCN Shares Outstanding History — Cyclerion Therapeutics Share Count Over Time
As of 5/10/2026 Cyclerion Therapeutics has 4.33 million CYCN shares outstanding. Investors often track the CYCN shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CYCN share count trends over time, with 31 historical shares outstanding datapoints presented, dating back to 3/18/2019.
| CYCN Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CYCN Historical Shares Outstanding: +18.45% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CYCN Stock Price Chart |
| About Cyclerion Therapeutics Inc |
| Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company that focuses on developing treatments for serious diseases. Co.'s portfolio includes novel soluble guanylate cyclase (sGC) stimulators, namely praliciguat and olinciguat, as well as multiple research stage molecules. Praliciguat is a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc. for the treatment of rare kidney disease. Olinciguat is a vascular sGC stimulator that the Co. intends to out-license for cardiovascular diseases. Co. operates through the human therapeutics segment. We show 31 historical shares outstanding datapoints in our coverage of CYCN's shares outstanding history. Understanding the changing numbers of CYCN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CYCN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CYCN by allowing them to research CYCN shares outstanding history as well as any other stock in our coverage universe. |
| CYCN Current Stock Quote |
Quotes delayed 20 minutes  Free CYCN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CYCN Share Performance |
| Shares Outstanding Peers |
| Cyclerion Therapeutics (CYCN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CYH Shares Outstanding History CYPH Shares Outstanding History CYRX Shares Outstanding History CYT Shares Outstanding History CYTH Shares Outstanding History CYTK Shares Outstanding History CYTR Shares Outstanding History CYTX Shares Outstanding History DARE Shares Outstanding History DAWN Shares Outstanding History More Healthcare companies » |
CYCN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
